Taking into consideration the latest data on psoriasis problems, namely: a number of uncertain links of etiopathogenesis, possible consistency of disorders of immune system, thyroid and skin microbial landscape as well as failure to achieve long-term and controlled remission demonstrate the relevance and feasibility of further research of dermatosis, which will contribute to improving quality of life for patients by using appropriate methods of therapeutic correction. The aim of our research was to study of skin microbial landscape and immune-endocrine parameters as well as improvement of treatment efficiency in patients with different clinical course of psoriasis by using narrowband UVB phototherapy.
There is a group of coagulation inhibitors, which are antiphospholipid antibodies (APLA). In patients with different phospholipid antibodies, recurrent thrombolytic therapy complications, brain lesions and pregnancy pathology were observed, which allowed identifying APLA syndrome
Making the diagnosis ad oculus in dermatovenereology has been used in practice from ancient times and to the present day. However, modernity and adherence to protocols require dermatologists to use in their practice a number of instrumental and hardware associated techniques and methods for making a diagnosis, which allow determining not only the type, but also, most importantly, the cause of the disease. An early diagnosis is often a decisive factor in the treatment of patients. The punch biopsy followed by histopathological examination is usually the key research method to make or confirm the final diagnosis in complex dermatology cases.
Рatients with diabetes have more complications and higher mortality from COVID-19. This is due to the fact that diabetes impairs the immune response. Hyperglycemia causes a violation of the immune response, which in turn cannot control the spread of pathogenic microorganisms and therefore patients with diabetes are more susceptible to infections. The purpose of the work ₋₋ analysis of bibliometric databases of literature on new developments in diabetes and COVID-19 and focused on clinical recommendations for patients with diabetes infected with COVID-19. The search methods included a literature review of scientific articles that studied diabetes and COVID-19.
According to the results of the analysis of the articles obtained as a result of the search in the PubMed, SCOPUS, Web of Science, MedScape databases, a combination of the terms “diabetes and SARS-CoV-2”, “diabetes and COVID-19”, “pathogenesis of diabetes in case of COVID-19”, "pancreas", "clinical features", "diagnosis", "treatment", "clinical recommendations", we found 32 messages from 2020 to 2022. The main parameters of the study were outpatients and inpatients with diabetes and COVID-19 of middle and elderly age starting from 46 years
and up to 82 years of age in France, China, the USA, Great Britain, in which a nationwide, retrospective, populationbased study was conducted. The following concomitant diseases are included in the main studies: arterial hypertension, cardiovascular diseases, heart failure, chronic kidney disease, chronic obstructive pulmonary disease, myocardial infarction, cerebrovascular diseases. Issues of pathogenetic mechanisms in DM and COVID-19, as well as management of patients with DM and COVID-19 are highlighted.
The increase in the frequency of toxic-allergic diseases is the result of an increase in the number of drugs on the pharmaceutical market, which leads to mass self-medication of the population. Most often, patients seek medical help after self-medication, using drugs of various pharmacological groups. Stevens-Johnson syndrome is the most common side effect of the drug.